Friday April 17 th PRELIMINARY PROGRAM - UPDATED: 19/04/ :00-17:30 h.

Transcription

1 Friday April 7 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 6:00-7:30 h. 6:00 7:30 Auditorium A Track: Training in Dual Diagnosis 6:00 7:30 Auditorium B Track: Psychotherapeutic Treatment in Dual 6:00 7:30 Room Track: Behavioral addictions / Gambling Debate Forum - DF0 DUAL DISORDERS IN SCIENTIFIC JOURNALS Pedro Ruiz, Department of Psychiatry & Behavioral Sciences, Miller School of Medicine University of Miami. FL, USA. JOURNAL OF DUAL DIAGNOSIS Alan Green, Department of Psychiatry, Dartmouth Medical School. NH, USA. REVISTA DE PATOLOGÍA DUAL Francisco J. Álvarez, Instituto de Estudios de Alcohol y Drogas, Universidad de Valladolid, España. EUROPEAN ADDICTION RESEARCH Wim van den Brink, University of Amsterdam/Amsterdam Institute for Addiction, The Netherlands. ACTAS ESPAÑOLAS DE PSIQUIATRÍA Miquel Roca, Universidad de las Islas Baleares. Mallorca, España. HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital, Pisa, Italy. ADVANCES ON DUAL DIAGNOSIS Gail Gilchrist, King's College London, United Kingdom. Symposium SY0 TREATMENT OF DUAL DISORDERS IN ADOLESCENTS AND YOUNG ADULTS WITH PSYCHOTHERAPY BASED ON NEUROPSYCHE PHYSIOLOGY AT HUMAN BIRTH Daniela Polese, University "Federico II" of Naples, Italy. THE POSSIBILITY OF TREATING DUAL DISORDERS IN YOUNG POPULATION THROUGH PSYCHOTHERAPY BASED ON NEUROPSYCHE PHYSIOLOGY AT HUMAN BIRTH Daniela Polese, University "Federico II" of Naples, Italy. SEVERE MENTAL ILLNESSES, DUAL DIAGNOSIS AND VIOLENCE: A PSYCHOTHERAPEUTIC PROSPECTIVE FOR FORENSIC PSYCHIATRY Niccolò Trevisan, Italian Society of Criminology, Italy. PSYCHOTHERAPY PRACTICE OF DUAL PSYCHOPATHOLOGY IN YOUNG IN A COOPERATIVE SERVICE OF MEDICAL PSYCHOTHERAPY Piera Galeandro, Cooperativa Sociale di Psicoterapia Medica, Italy. PRELIMINARY DATA FROM AN EARLY DETECTION STUDY CONDUCTED IN CHILD AND ADOLESCENT COMMUNITY CENTERS Paolo Fiori, "Sapienza" Università di Roma, Italy. Symposium SY0 IS EMOTIONAL DEPENDENCE A BEHAVIORAL ADDICTION WITHIN DUAL DISORDERS? Rosa Fernández-Marcote, UCA de Toledo. Hospital Provincial. SESCAM. Toledo, España. FRAMEWORK OF EMOTIONAL BEHAVIORAL ADDICTION UNIT AND WITHIN THE RANGE OF DUAL DIAGNOSIS Pág.

2 Friday April 7 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Mª Nieves Gómez, Ayuntamiento San Sebastian de los Reyes, Madrid, España. EMOTIONAL DEPENDENCY IN DAILY PRACTICES OF FAMILY PHYSICIANS: INTERVENTION AND BIOLOGISTIC BASIS Juan A. López, Hospital de Octubre, CS Las Calesas, Madrid, España. TRANSVERSAL EMOTIONAL DEPENDENCY TREATMENT IN A THERAPEUTIC COMMUNITY FOR DUAL PATIENTS 6:00 7:30 Room -3 Track: Multidisciplinary Intervention in Dual 6:00 7:30 Room 4 Track: Depression 6:00 7:30 Room 5 Track: Bipolar 6:00 7:30 Room 6 Track: Personality Symposium - SY03 BIOMARKERS IN DUAL DISORDERS Magi Farré, Institut Hospital del Mar d'investigacions Mèdiques-IMIM, Universitat Autònoma de Barcelona, España. BIOMARKERS IN PSYCHIATRY: AN OVERVIEW Rocío Martín-Santos, Institute of Neurosciences, Hospital Clínic, IDIBAPS, CIBERSM, España. ARE CYTOKINES BIOLOGICAL MARKERS OF DUAL DIAGNOSIS? Fernando Rodriguez de Fonseca, Instituto IBIMA, Hospital Carlos Haya de Málaga, España. NEW BIOINFORMATIC TOOL FOR SUPPORTING BIOMARKERS IDENTIFICATION FOR PSYCHIATRIC DISORDERS: PSYGENET Laura Furlong, Institut Hospital del Mar d'investigacions Mèdiques. Barcelona, España. Symposium - SY04 DUAL DISORDERS IN KETAMINE ADDICTION Wai Kwong Tang, The Chinese University of Hong Kong, China. PSYCHIATRIC MORBIDITY IN KETAMINE USERS Wai Kwong Tang, The Chinese University of Hong Kong, China. THE DIFFERENTIAL ROLES OF PSYCHOSOCIAL RISKS BETWEEN KETAMINE USERS AND BETEL BUT CHEWERS IN TAIWAN Kun-Hua Lee, Kao Yuli Hospital, Ministry of Health and Welfare, Taiwan. Symposium - SY05 BIPOLARITY AND ADDICTIVE DISORDERS Enrique Galli, Universidad Peruana Cayetano Heredia. Lima, Perú. BIPOLARITY AND COCAINE TO THE BRAIN SPECT Agata Salazar, Universidad Peruana Cayetano Heredia. Lima, Perú. PREVALENCE AND BIPOLAR CLINIC Carlos Ordoñez, Hospital Hermilio Valdizan. Lima, Perú. DUAL DIAGNOSIS NEUROTOXIC THEORY Enrique Galli, Universidad Peruana Cayetano Heredia. Lima, Perú. Symposium - SY06 COGNITIVE NEUROSCIENCE APPLIED TO PERSONALITY DISORDERS AND PSYCHOPATHY Pág.

3 Friday April 7 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 6:00 7:30 Room 7 Track: Post-Traumatic Stress 6:00 6:45 Room 8 Track: Useful Psychotropic Drugs 6:45 7:30 Room 8 Track: Psychosis 6:00 7:30 Room 9 Track: Child & Adolescent Psychiatry Guillermo N. Jemar, Hospital Borda, Asociación Neuropsiquiátrica Argentina, Argentina. NEUROBIOLOGY OF ANTISOCIAL BEHAVIOR AND NEUROBIOLOGICAL APPROACHES TO PSYCHOPATHOLOGY Martin Mazzoglio y Nabar, Asociación Neuropsiquiátrica Argentina - Servicio Penitenciario Federal Argentina, Argentina. THE ETHICAL AND LEGAL ASPECTS IN PERSONALITY DISORDERS AND PSYCHOPATHY Ramiro Isla, Asociación Neuropsiquiátrica Argentina - Defensoría General de La Nación, Argentina. Symposium - SY07 LATEST DEVELOPMENTS IN SIMULTANEOUS TREATMENT OF TRAUMA AND ADDICTION Ayna Johansen, Norwegian Centre for Addiction Research, University of Oslo, Norway. CONCURRENT TREATMENT OF POST-TRAUMATIC STRESS DISORDER AND ALCOHOL DEPENDENCE IN WOMEN IN A SWEDISH SETTING - A PILOT STUDY Anna Persson, Karolinska Institutet. Solna, Sweden. A RATIONALE FOR EMOTION-FOCUSED TREATMENT FOR COMORBID SUBSTANCE USE DISORDER AND POST-TRAUMATIC STRESS Shedeh Tavakoli, Northeastern Illinois University, Chicago. IL, USA. THERAPIST EXPERIENCES AND TRAINING NEEDS FOR TREATING SIMULTANEOUS TRAUMA AND ADDICTION Ingerid E. Bjelland, Frogn Kommune, Norway. Main Lecture - ML0 DRUGS AS MEDICATIONS IN DUAL DISORDERS Carlos Roncero, Universidad Autónoma de Barcelona, España. Speaker: Rafael Maldonado, Universidad Pompeu Fabra. Barcelona, España. Main Lecture - ML0 ARE EXISTING PSYCHIATRIC DIAGNOSES ABLE TO DESCRIBE DUAL DISORDERS IN THE LIGHT OF A WIDENING COMORBIDITY? José M. Goikolea, Hospital Clinic, Barcelona, España. Speaker: Pier Maria Furlan, Dept. of Mental Health and Drug Abuse, Turin, Italy. Symposium - SY08 ENHANCING CARE FOR ADOLESCENTS WITH DUAL DISORDERS: OUTREACH PREVENTION EFFORTS, PEDIATRIC HEALTH EVALUATIONS AND SUICIDAL RISK ASSESSMENT Pág. 3

4 Friday April 7 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Gabriel Kaplan, Bergen Regional Medical Center, Paramus. NJ, USA. CANNABIS HEALTH RISKS AND PREVENTION PROGRAMS Mònica Prat, Hospital Universitari Vall d'hebron. Barcelona, España. PEDIATRIC HEALTH EVALUATION Donald E. Greydanus, Western Michigan Univ. SchooloOf Medicine, Kalamazoo. MI, USA. SUICIDAL RISK ASSESSMENT Gabriel Kaplan, Bergen Regional Medical Center, Paramus. NJ, USA. 6:00 6:45 Room 0 Track: Multidisciplinary Intervention in Dual 6:45 7:30 Room 0 Track: Personality 6:00 6:45 Room Track: Training in Dual Diagnosis Workshop - WS0 ASSERTIVE OUTREACH SERVICES IN DUAL DISORDERS. STATE OF THE ART, AND THE NORWEGIAN SOLUTION IN COMMITTED, COMMUNITY COLLABORATION - THE C-FLEX MODEL Bror Just Andersen, Baerum DPC, Veste Viken HT, Norway. INTERDISCIPLINARY ASSERTIVE OUTREACH TEAMS IN DUAL DISORDERS - STATE OF THE ART Lars Linderoth, Vestre Viken HT/Baerum DPC, Norway. THE DEVELOPMENT, EXPERIENCE AND SUCCESS FACTORS WITH THE C-FLEX TEAM Kjetil Emilsen, Vestre Viken HT/Baerum DPC, Norway. THE WAY AHEAD - ESTABLISHING A C-FLEX YOUTH TEAM Aslak Woien Augedal, Vestre Viken HT/ Division of Mental Health And Addiction, Norway. METHODICAL APPROACH AND RESULTS OF THE EFFECT EVALUATION OF THE C-FLEX TEAM - THREE YEARS OF MODEL TESTING Bror Just Andersen, Baerum DPC, Veste Viken HT. Norway. Workshop - WS0 THE USE OF EAR ACUPUNCTURE TO AID IN RETENTION OF THOSE WITH BORDERLINE PERSONALITY DISORDER IN SUBSTANCE ABUSE TREATMENT Chair/Speaker: Elizabeth B. Stuyt, Colorado Mental Health Institute at Pueblo, Pueblo. CO, USA. Symposium SY09 PROTOCOLS OF INTERVENTION IN DUAL PATHOLOGY Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. Carlos Roncero, Universidad Autónoma de Barcelona, España. José Martínez-Raga, Unidad de Conductas Adictivas de Gandía, CEU Cardenal Herrera. Valencia, España. Pág. 4

5 Friday April 7 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 6:45 7:30 Room 6:00 7:30 Room Special Lecture SL0 DUAL PATHOLOGY AND ART Co-organized by the Foundation on Dual Lara Grau-López, Hospital Universitari Vall d Hebron. Barcelona, España. Speaker: J. Ramon Pigem, Clínica Bellavista, Lleida, España. Oral Communications - OC0 Chairs: José Antonio Navarro, Hospital Universitario Vall d Hebron de Barcelona/Clínica Galatea. Barcelona, España. Cecilia Idiarte, Sociedad de Psiquiatría del Uruguay, Uruguay. EXECUTIVE FUNCTIONING, SUICIDE ATTEMPTS AND SUBSTANCE RELAPSES IN PATIENTS WITH AND WITHOUT PSYCHIATRIC COMORBIDITY I. Benaiges, S. López-Vera J. E. Marquez-Arrico, G. Prat, A. Adan, Department of Psychiatry and Clinical Psychobiology, University of Barcelona, Barcelona, España. Institute for Brain, Cognition and Behavior (IR3C), Barcelona, España. CANNABIS: SU INFLUENCIA A LO LARGO DE UN AÑO EN LOS INTENTOS DE SUICIDIO M. Canal Rivero,, A. Yañez Castro, G. Benítez Rodriguez, J. García Egea, Jordi E. Obiols, M. Ruiz Veguilla,3 Hospital Universitario Virgen del Rocío. Sevilla, España. Facultat de Psicología. Departament de Psicología Clínica i de la Salut. Universitat Autònoma de Barcelona, España. 3 Instituto de Biomedicina de Sevilla (IBIS), España. PERSONALITY DISORDERS, SUBSTANCE USE DISORDER AND CRIMINAL BEHAVIOR Anna C. S. Chaves University of São Paulo, São Paulo, Brasil. PERIPHERAL TEMPERATURE CIRCADIAN RHYTHM IN PATIENTS WITH DUAL DIAGNOSIS: MENTAL DISORDER AS A MODULATING FACTOR S. López-Vera, I. Benaiges, J.A. Madrid, A. Adan,3 Department of Psychiatry and Clinical Psychobiology, University of Barcelona, España. Chronobiology Laboratory, Department of Physiology, University of Murcia, España. 3 Institute for Brain, Cognition and Behavior (IR3C), Barcelona, España. THE CO-MORBIDITY BETWEEN SUICIDE VICTIMS IN THE DISTRICT OF TIRANA, OVER THE TIME PERIOD Pasho Maksuti, Vuksan Kola, Artan Simaku 3 UHC (University Hospital Centre) Mother Theresa, Tirana, Albania. Pág. 5

6 Friday April 7 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Institute of Public Health, Tirana, Albania. FOCUS GROUPS: A METHOD FOR DEVELOPING GUIDELINES FOR DUAL DIAGNOSIS F. Matthys, P. Joosten, W. van den Brink 3, B. Sabbe 4 University Hospital Brussels and Vrije Universiteit Brussels (VUB), The Netherlands. Psychiatric Centre Broeders Alexianen, Tienen, Belgium. 3 Amsterdam Institute for Addiction Research, Department of Psychiatry, Academic Medical Center,University of Amsterdam, Amsterdam, The Netherlands. 4 Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium. ADDICTION AND MENTAL PRODUCTIONS IN TRAUMATIC PATHOLOGIES Freddy nyegue, Mlle Laurine Fort Centre Psychothérapique de Laxou/ Nancy, France. Université de Lorraine, France. THE EFFECT OF ACADEMIC SELF-EFFICACY AND SELF-AWARENESS ON ACADEMIC ACHIEVEMENT IN STUDENTS WITH LEARNING DISABILITY (LD) Moluk Khademi Ashkezari, Salehe Piryaei Alzahra University, Tehran, Iran. 7:30-8:30 h. 7:30 8:30 Auditorium A Track: Opioid System and Dual Plenary Session - PS0 TREATMENT AND 4-MONTH FOLLOW-UP OF PRESCRIPTION OPIOID DEPENDENCE: THE ROLE OF DUAL DISORDERS Miguel Casas, Universitat Autònoma de Barcelona, Hospital Universitari Vall d Hebron. Barcelona, España. Speaker: Roger Weiss, Harvard Medical School/division of Alcohol and Drug Abuse, McLean Hospital, Belmont. MA, USA. Pág. 6

7 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 08:30 0:00 h. 08:30 0:00 Auditorium A Track: Attention Deficit 08:30 0:00 Auditorium B Track: Spirituality and Dual 08:30 09:5 Room Track: Training in Dual Diagnosis 09:5 0:00 Room Track: Basic Research Symposium SY0 MANAGEMENT OF SUBSTANCE USE DISORDERS IN PATIENTS WITH ADHD Josep A. Ramos-Quiroga, Hospital Universitari Vall d'hebron. Barcelona, España. TREATMENT OF COCAINE DEPENDENCE IN ADULTS WITH ADHD Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA. ADHD MEDICATION USE AND MISUSE IN ADOLESCENCE Geurt van de Glind, Amsterdam Institute for Addiction Research. Amsterdam, The Netherlands. TRAUMA IN SUD PATIENTS WITH AND WITHOUT ADHD Maija Konstenius, Department of Clinical Neuroscience, Division of Psychiatry, Karolinska Institutet. Solna, Sweden. IS THE METHYLXANTHINE'S CONSUMPTION INCREASED IN ADULTS WITH ADHD? Josep A. Ramos-Quiroga, Hospital Universitari Vall d'hebron. Barcelona, España. Debate Forum - DF0 TRASCENDENCE OF SPIRITUALITY AND DUAL DISORDERS Adolf Tobeña, Catedrático de Psiquiatría y Psicología Médica. Universitat Autònoma de Barcelona, España. SELF-HELP AND SPIRITUALITY Adil Qureshi, Universitat Autònoma de Barcelona, Hospital Vall d'hebron. Barcelona, España. INTERVIEW ON SPIRITUALITY IN DUAL PATIENTS Jaime Roig, Centre Medic Alella. Barcelona, España. Main Lecture - ML03 DUAL DISORDERS IN THE JOURNAL ADDICTION Miquel Roca, Universidad de las Islas Baleares. Mallorca, España. Speaker: Robert West, Health Behavior Research, Department of Epidemiology, University College London, United Kingdom. Main Lecture - ML04 DELAYED GRATIFICATIONS AND DUAL PATHOLOGIES: THE PRICE OF MODERNITY Joan Colom, Agència de Salut Pública de Catalunya, España. Speaker: Ruben Baler, National Institute on Drug Abuse, Bethesda. MD, USA. Pág. 7

8 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 08:30 0:00 Room -3 Track: Cannabis and Dual 08:30 0:00 Room 4 Track: Personality 08:30 0:00 Room 5 Track: Transcultural Psychiatry Invited Symposium - IS0 THE ONGOING DEBATE: CANNABIS AND DUAL DISORDERS Amine Benyamina, Centre d'enseignement, de Recherche et de Traitement des Addictions. Paris, France. CANNABIS ABUSE AND SHORT PSYCHOTIC EPISODES Mehdi Paes, Mohamed V Universityin Rabat, Morocco. CANNABIS USE IN CHRONIC SCHIZOPHRENIA PATIENTS Carmen Barral, Hospital Universitari Vall d'hebron. Barcelona, España. CANNABIS AND OTHER DRUGS: USE AMONG DUAL DISORDERS PATIENTS WITH PERSIST MENTAL ILLNESS. A 7 YEARS LONGITUDINAL FOLLOW-UP STUDY Kim T. Mueser, Boston University, USA. Symposium - SY RELEVANCE OF SUBSTANCE USE DISORDERS (SUD) IN A LONG LIFESPAN: PROGRAM OF TPL BARCELONA GROUP Marc Ferrer, Hospital Universitari Vall d'hebron. Barcelona, España. THE IMPORTANCE OF SUBSTANCE USE DISORDER IN A PROGRAM FOR THE BORDERLINE PERSONALITY DISORDER (BPD) THROUGHOUT LIFE Mercè Gibert, Universitat Autònoma de Barcelona, Hospital Vall d'hebron. Barcelona, España. THE IMPORTANCE TO TREAT THE SUBSTANCES USE DISORDER COMORBIDITY Joan Vegué, Universitat Autònoma de Barcelona, Servei de Psiquiatria en Hospital Vall d'hebron. Barcelona, España SUBSTANCE USE DISORDERS (SUD) IN BORDERLINE PERSONALITY DISORDER (BPD): INFLUENCE AT CLINICAL MANIFESTATION Natalia Calvo, Universitat Autònoma de Barcelona, Hospital Vall d'hebron. Barcelona, España. Invited Symposium - IS0 DUAL DISORDERS IN THE MODERN WORLD: TRANSCULTURAL APPROACH Dinesh Bhugra, King s College London, United Kingdom. CULTURAL INTERVIEW IN DUAL PATIENTS Francisco Collazos, Hospital Universitari Vall d'hebron, Barcelona, España. IMMIGRATION, SOCIAL PSYCHIATRY AND DUAL PATHOLOGY Dinesh Bhugra, King s College London, United Kingdom. IS DUAL DISORDER DIFFERENT IN LATIN POPULATIONS AMONG LATINOS IN USA? Margarita Alegria, Center for Multicultural Mental Health Research, Cambridge Health Alliance & Harvard Medical School, Somerville. MA, USA. Pág. 8

9 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 08:30 0:00 Room 6 Track: Multidisciplinary Intervention in Dual 08:30 0:00 Room 7 Track: Psychopharmacological Treatments in Dual 08:30 0:00 Room 8 Track: Psychotherapeutic Treatment in Dual Symposium - SY BIOLOGICAL RHYTHMS AND DUAL DISORDERS. A NON NEGLIGIBLE CONNECTION Ana Adan, Instituto de Investigación en Cerebro, Cognición y Conducta de la Universidad de Barcelona, España. CHRONOBIOLOGY AND DUAL DISORDERS. THE CURRENT STATE OF KNOWLEDGE Sílvia López-Vera, Universitat de Barcelona. Barcelona, España. RHYTHMIC IMPAIRMENT AND MODULATING FACTORS IN PATIENTS WITH DUAL DIAGNOSIS Irina Benaiges, Universitat de Barcelona. Barcelona, España. CLINICAL IMPLICATIONS OF RHYTHMIC IMPAIRMENT IN SUBSTANCE USE DISORDERS AND DUAL DIAGNOSIS Ana Adan, Instituto de Investigación en Cerebro, Cognición y Conducta de la Universidad de Barcelona, España. Debate Forum - DF03 DRUGS FOR USE IN CONDITIONS DIFFERENT TO THOSE AUTHORIZED IN DUAL DISORDERS: CONSENSUS OF THE SEPD Francisco J. Álvarez, Institute for The Study of Alcohol and Drugs, Universidad de Valladolid, España. CONSENSUS OF SEPD ON DUAL BIPOLAR DISORDER TREATMENT Vicent Balanzá, La Fe University and Polytechnic Hospital, University of Valencia, CIBERSAM. Valencia, España. CONSENSUS OF SEPD ON DUAL DISORDER ANXIETY TREATMENT Marisa Dorado, Unidad de Conductas Adictivas De Gandía. Valencia, España. CONSENSUS OF SEPD ON DUAL DISORDER DEPRESSION TREATMENT: PRELIMINARY PROPOSAL OF THE WORKING GROUP Pablo Vega, Instituto de Adicciones. Madrid, España. Debate Forum - DF04 HOW TO STOP THE TRAIN BEFORE IT CRUSHES OR DERAILS? ASSESSMENT AND PREVENTION OF DUAL PATHOLOGY IN ADOLESCENCE Rosa Fernández-Marcote, UCA de Toledo, Hospital Provincial, SESCAM. Toledo, España. EFFECTIVE PSYCHOLOGICAL INTERVENTIONS IN ADOLESCENTS WITH DUAL PATHOLOGY. FROM PREVENTION TO TREATMENT Lorena Casete, Unidad Asistencial de Drogodependencias. ACLAD. A Coruña, España. DUAL TEENS Raquel Vidal, Hospital Universitari Vall de Hebrón. Barcelona, España. WHAT ABOUT "OUR" TEENS? CODEPENDENCIES AND RISKS Angel M. Turbi, Universidad Católica de Valencia. S Vicente Mártir. Valencia, España. PSYCHOMETRIC EVALUATION TOOLS IN DUAL PATHOLOGY Pág. 9

10 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Constanza Daigre, Servicio de Psiquiatría Hospital Universitario Vall d Hebron, Barcelona, España. 08:30 0:00 Room 9 08:30 0:00 Room 0 Track: Alcohol 08:30 09:5 Room Track: Epidemiology and Dual 09:5-0:00 Room Track: Child & Adolescent Psychiatry Medical Educational Room Sponsored by the Foundation on Dual Symposium - SY3 NOVEL APPROACHES TO UNDERSTANDING AND TREATING COMORBID DEPRESSION AND ALCOHOL MISUSE Marie-Eve Couture, Dalhousie University. Halifax, Canada. A QUALITATIVE STUDY OF DRINKING TO COPE WITH DEPRESSION Marie-Eve Couture, Dalhousie University. Halifax, Canada. CONTEXT COUNTS: SOLITARY DRINKING EXPLAINS THE ASSOCIATION BETWEEN DEPRESSIVE SYMPTOMS AND ALCOHOL-RELATED PROBLEMS Matthew Keough, Concordia University. Montréal, Canada. THE EFFECTS OF DEPRESSION LEVEL AND ALCOHOL ADMINISTRATION ON POSITIVE AND NEGATIVE POST-EVENT RUMINATION: AN EXPERIMENTAL STUDY Sherry H. Stewart, Dalhousie University. Halifax, Canada. INTERVENING WITH HOPELESSNESS REDUCES AND PREVENTS DEPRESSION AND ALCOHOL MISUSE IN ADOLESCENTS Patricia Conrod, Université de Montréal, Canada. Main Lecture - ML05 CORMORBIDITY OF SUBSTANCE AND PSYCHIATRIC DISORDERS: EPIDEMIOLOGIC FINDINGS, NEW DIRECTIONS Pere Bonet, Pere Bonet Gabinet Psiquiatria i Psicologia Clínica, Manresa. Barcelona, España. Speaker: Deborah Hasin, New York State Psychiatric Institute, Columbia University. NY, USA. Workshop - WS03 ADOPTED AND NON-ADOPTED TEENAGERS AND YOUNG ADULTS WITH DUAL DISORDERS: DIFFERENTIAL DIAGNOSTIC CHARACTERISTICS Jordi Royo, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España. ADOPTED AND NON-ADOPTED ADOLESCENTS: CRITERIA FOR RESIDENTIAL ADMISSION TO SPECIALISED HEALTHCARE FACILITIES Ramon Martí, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España. COMPARATIVE DIAGNOSTIC STUDY IN ADOPTED AND NON-ADOPTED ADOLESCENTS AND Pág. 0

11 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 YOUNG ADULTS AT SPECIALISED HEALTHCARE CENTRES Cristina Baliarda, AMALGAMA7 - Atención Terapéutica y Educativa para Adolescentes, Jóvenes y sus Familias. Barcelona, España. 08:30 0:00 Room Oral Communications - OC0 Chairs: Nicolás Ramírez, Hospital Sant Rafael, Barcelona, España. Ligia Chavez, Universidad de Puerto Rico. San Juan, Puerto Rico. TIME TREND ANALYSIS OF PATIENTS WITH DUAL SEEKING TREATMENT FROM DUAL DIAGNOSIS CLINIC OF A TERTIARY CARE SUBSTANCE USE DISORDER TREATMENT CENTRE IN INDIA Y.P.S.Balhara, R. Gupta, R. Lal India Institute of Medical Sciences (AIIMS), New Delhi, India. PERPETRATOR OF FACTITIOUS DISORDER ON ANOTHER RECEIVES AN INTERNAL SELF- REWARD IN THE MEDICAL ENVIRONMENT. ADDICTIVE BEHAVIOR? M. López-Rico, J. López-Sánchez López J., J.L. Jiménez Hernández Facultad de Medicina. Universidad de Salamanca, España. Hospital "Doce de Octubre". Madrid, España. PSYCHIATRIC DISORDERS AND HIV-HCV COINFECTION: NEED FOR BETTER SCREENING AND CONTINUOUS CARE L. Michel, M. Winnock, C. Protopopescu 3, M.A. Loko, J.P. Lang 4, B. Spire 3, D. Salmon 5, F. Dabis 3, M.P. Carrieri 3 Centre Pierre Nicole; Inserm, U669, Paris, France. Inserm, U897, ISPED, Bordeaux, France. 3 Inserm, (SESSTIM), Marseille, France. 4 CHRU Strasbourg, Strasbourg, France. 5 Hôpital Cochin Port-Royal, Paris, France. A BROAD UNDERSTANDING OF GAMING ADDICTION: GAMERS THOUGHTS, PERCEPTIONS AND BEHAVIOURS IN GAME TRANSFER PHENOMENA A. Ortiz de Gortari, M.D Griffiths Nottingham Trent University, Nottingham, United Kingdom. DRUG AND SYMPTOMS OF PATHOLOGICAL GAMBLING IN COLOMBIAN PRISON POPULATION J. Ruíz Pérez, O. Garay Quevedo, L. Rueda Useche Facultad de Ciencias Humanas, Universidad Nacional de Colombia, Bogotá, Colombia. DETERMINE THE EFFECT OF TREATMENT ON RETENTION AMONG DRUG USERS Peymaneh Shirinbayan, Hassan Rafiey, Afshin Vejdani Roshan, Asghar dadkhah, Ali Farhoudian Pág.

12 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 University of Social welfare and rehabilitation sciences, Tehran, Iran. AUTISM SPECTRUM DISORDERS IN DUAL-DIAGNOSIS PATIENTS PREVALENCE STUDY CONDUCTED AT A DUAL DIAGNOSIS TREATMENT FACILITY A.E. Bonebakker, S. van Nieuwerk, R. Vuijk, P. Blanken 3 Palier Centre for Dual, The Hague, The Netherlands. Sarr Expertise Centre of expertise in autism, Rotterdam, The Netherlands. 3 Parnassia Addiction Research Centre, The Hague, The Netherlands. DSM-IV DIAGNOSES AMONG A COMMUNITY SAMPLE OF CHINESE ADOLESCENTS: RATES AND PATTERNS OF COMORBIDITY Patrick Leung The Chinese University Of Hong Kong, China. SYSTEMS OF CARE FOR DUAL DISORDERS: THE CANADIAN EXPERIENCE N. El-Guebaly University of Calgary, Alberta, Canada. 0:00 :00 h. 0:00 :00 Room 0:00 :00 Room -3 SATELLITE Symposium Industry Session not included in official scientific programme CME/CPD SATELLITE Symposium Industry Session not included in official scientific programme CME/CPD 0:00 :00 Room 6 SATELLITE Symposium Industry Session not included in official scientific programme CME/CPD :00 4:00 h. :00 4:00 Room :00 4:00 Room -3 :00 4:00 Room SATELLITE Symposium Industry Session not included in official scientific programme CME/CPD SATELLITE Symposium Industry Session not included in official scientific programme CME/CPD Supported WORKSHOP Industry Session not included in official scientific programme CME/CPD Pág.

13 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 4:00 5:30 h. 4:00 5:30 Auditorium A Track: Tobacco 4:00 5:30 Auditorium B Track: Personality Invited Symposium - IS03 SMOKE IN YOUR EYES Robert West, Health Behavior Research, Department of Epidemiology, University College London, United Kingdom. DEPRESSION AND ADDICTION, DOES TOBACCO AFFECT Eugeni Bruguera, Hospital Universitari Vall d'hebron. Barcelona, España. TREATMENT OF TOBACCO DEPENDENCE AND ITS INFLUENCE ON OTHER ADDICTIONS Robert West, Health Behavior Research, Department of Epidemiology, University College London, United Kingdom. CHOLINERGIC SYSTEM AND TOBACCO AND DUAL DISORDERS Manuel Gurpegui, Universidad de Granada, España. Debate Forum - DF05 PERSONALITY FEATURES OR PERSONALITY DISORDERS: DOES IT MATTER IN DUAL DISORDERS? Jose L. Carrasco, Universidad Complutense de Madrid, España. THERAPEUTIC STRATEGIES OF SUBSTANCE USE DISORDER WITH COMORBIDITY OF BORDERLINE PERSONALITY DISORDER Miquel Gasol, Psiquiatría y Psicología del Hospital General de Catalunya. Barcelona, España. TRAITS, TROUBLES AND SUBSTANCE USE Lola Peris, Centre de Neuchâtelois de Psychiatrie (CNP) Neuchàtel, Switzerland. THE IMPORTANCE OF (SUBSTANCE USE DISORDER) SUD IN THE COMPLEX PATHOGENESIS OF (BORDERLINE PERSONALITY DISORDER) BPD Marc Ferrer, Hospital Universitari Vall d'hebron. Barcelona, España. 4:00 5:30 Room Track: Basic Research Invited Symposium - IS04 ARE GENETICS RISK FACTORS FOR DUAL DISORDERS? Henry R. Kranzler, Perelman School of Medicine, University of Pennsylvania. Treatment Research Center. PA, USA. CANNABIS USE AND SCHIZOPHRENIA FROM THE PERSPECTIVE OF THE GENETIC FACTORS Araceli Rosa, Universidad de Barcelona, España. GENETIC RISK FACTORS FOR DRUG ADDICTION Noelia Fernández, Genetics Department, UB. CIBERER. Barcelona, Spain. POLYMORPHISMS AND THE EFFICACY OF METHADONE Francina Fonseca, Hospital del Mar. Barcelona, España. Pág. 3

14 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 4:00 5:30 Room -3 Track: Cannabis and Dual Invited Symposium - IS05 CANNABIS, PSYCHOSIS AND DUAL DISORDERS Alan Green, Department of Psychiatry, Dartmouth Medical School, Lebanon. MD, USA. FIRST PSYCHOTIC EPISODES; CANNABIS AND DUAL PATHOLOGY Luis San, Hospital Sant Joan de Deu. Barcelona, España. EVALUATION OF CANNABIS CONSUMPTION IN PSYCHOTIC DUAL PATIENTS Alan Green, Department of Psychiatry, Dartmouth Medical School, Lebanon. MD, USA. USE OF CANNABIS AND ITS INFLUENCE IN ON DEVELOPMENT Miguel Ruiz-Veguilla, Hospital Virgen del Rocío. Sevilla, España. 4:00 5:30 Room 4 Track: Training in Dual Diagnosis 4:00 5:30 Room 5 Track: Evaluation processes in Dual 4:00 5:30 Room 6 Track: Psychosis Symposium SY4 THE CONVERGENCE OF ADDICTION MEDICINE AND DUAL DISORDERS Session in collaboration with ISAM, ACAPI and SEPD Gregory Bunt, International Society of Addiction Medicine, NYU School of Medicine. NY, USA. Néstor Szerman, Servicio Salud Mental Retiro, Hospital General Universitario Gregorio Marañón. Madrid, España. Nady El-Guebaly, University of Calgary. Alberta, Canada. Javier Didia, Hospital Italiano de Buenos Aires y Universidad de Buenos Aires, Argentina. Symposium - SY5 NEUROPSYCHOLOGICAL PERFORMANCE ON DUAL DISORDERS Ana Adan, Instituto de Investigación en Cerebro, Cognición y Conducta de la Universidad de Barcelona, España. NEUROPSYCHOLOGICAL IMPACT OF DUAL DISORDERS. CURRENT KNOWLEDGE Gemma Prat, Universitat de Barcelona, España. NEUROPSYCHOLOGICAL ASSESSMENT IN DUAL DISORDER PATIENTS. SELECTING TASKS TO OPTIMIZE THE EVALUATION Carlos Jacas, Hospital Universitari Vall d'hebron. Barcelona, España. NEUROCOGNITIVE PERFORMANCE OF DUAL SCHIZOPHRENIA: A POSSIBLE BIOMARKER Irina Benaiges, Universitat de Barcelona, España. Symposium SY6 FETAL ALCOHOL SPECTRUM DISORDER AS A GENERATOR OF DUAL PATHOLOGY Montse Pàmias, Corporació Sanitaria I Unviersitari Parc Taulí, Sabadell. Barcelona, España. EAF: EPIDEMIOLOGY AND A SKI CLINIC Anna Sans, Hospital Sant Joan de Déu D' Esplugues. Barcelona, España. Pág. 4

15 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 NEUROPSYCHOLOGY AND LEARNING IN THE EAF Natália Picó, Fundació Institut de Psicologia. Barcelona, España. PSYCHIATRIC COMORBIDITY IN THE EAF Núria Gómez, Hospital Universitari Vall d Hebron. Barcelona, España. 4:00 5:30 Room 7 Track: Alcohol 4:00 5:30 Room 8 Track: Psychotherapeutic Treatment in Dual 4:00 5:30 Room 9 4:00 5:30 Room 0 Track: Transcultural Psychiatry Symposium - SY7 ALCOHOL AND AGRESSION: AN INTIMATE RELATIONSHIP! Sandra Queirós, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal. ALCOHOL AND SEXUAL ASSAULT Sandra Queirós, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal. ALCOHOL AND AGRESSION - VICTIMS AND THE SNOWBALL EFFECT Tânia Abreu, Centro Hospitalar Tamega E Sousa. Penafiel, Portugal. ALCOHOL, SEVERE MENTAL ILLNESS AND AGRESSION Catarina Freitas, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal. ALCOHOL, ANTISOCIAL PERSONALITY AND AGRESSION Teresa Sousa-Ferreira, Centro Hospitalar Tamega e Sousa. Penafiel, Portugal. Debate Forum - DF06 EFFECTIVENESS OF PSYCHOLOGICAL TREATMENTS IN DUAL PATHOLOGY AND ADEQUACY OF RESOURCES. HAVE WE CHANGED ONE ADDICTION FOR ANOTHER? Rosa Fernández-Marcote, UCA de Toledo. Hospital Provincial. SESCAM. Toledo, España. PSYCHOLOGICAL INTERVENTION IN DUAL PATHOLOGY: AN INTEGRATED NETWORK MODEL OF SOCIAL AND HEALTH RESOURCES IN THE CITY OF BARCELONA Cristo M. Cruz, Centre d'atenció i Seguiment Sarrià. Barcelona, España. TREATMENT, EFFICACY AND THE FIGURE OF THE PSYCHOTHERAPIST Mª Elena Bernal, Servicio Provincial de Drogodependencias de la Diputación de Almería, España. PSYCHOTHERAPIES IN DUAL PATHOLOGY Diana Kushner, Universidad de Santiago de Chile. Santiago, Chile. EVOLUTION OF TREATMENT PROGRAMS IN DUAL PATHOLOGY Abel Baquero, PPDG Consorcio Hospitalario Provincial de Castellón. Comunidad Valenciana, España. Medical Educational Room Sponsored by the Foundation on Dual Symposium - SY8 IDENTIFYING STRATEGIES FOR IMPROVING CARE FOR LATINO IMMIGRANTS WITH DUAL DISORDERS IN SPAIN AND THE U.S.: RESULTS FROM THE INTERNATIONAL LATINO RESEARCH PARTNERSHIP Pág. 5

16 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Margarita Alegria, Harvard Medical School, Somerville. MA, USA. COMPARISON OF MENTAL HEALTH TREATMENT EXPENDITURES AMONG PATIENTS WITH DUAL DISORDERS IN USUAL PSYCHIATRIC CARE BETWEEN MADRID AND BOSTON HOSPITAL SYSTEMS Rodrigo Carmona, Fundación Jiménez Diaz. Madrid, España. AN INTERNATIONAL COMPARISON OF EPISODES OF SUBSTANCE ABUSE TREATMENT AMONG NATIVE-BORN AND LATINO IMMIGRANTS IN PUBLIC HOSPITAL SETTINGS IN BARCELONA AND BOSTON Adil Qureshi, Universitat Autònoma de Barcelona, Hospital Vall d'hebron. Barcelona, España. COMMONALITIES AND DIFFERENCES IN BEHAVIORAL HEALTH CARE FOR LATINO POPULATIONS IN PRIMARY CARE Daniel Gonzalez, Cambridge Health Alliance, Somerville. MA, USA. THE TESTING OF THE AC-OK WITH AN INTERNATIONAL SAMPLE OF LATINO IMMIGRANTS Ligia Chavez, Universidad de Puerto Rico. San Juan, Puerto Rico. 4:00 4:45 Room Track: Child & Adolescent Psychiatry 4:45 5:30 Room Track: Personality Workshop - WS04 ADDICTIONS AND DUAL DISORDERS IN JUVENILE JUSTICE Rosa de Sta. Mª Pérez, Parc Sanitari Sant Joan de Deu. Barcelona, España. MENTAL HEALTH CARE AND SUBSTANCE ABUSE IN YOUNG OFFENDERS: AN INTEGRATIVE APPROACH TO HEALTH CARE IN THE FIELD OF JUVENILE JUSTICE IN SPAIN Jorge M. Garcia, Hospital Punta de Europa de Algeciras. Cádiz, España. VULNERABILITY AND DUAL PATHOLOGY IN YOUNG OFFENDERS Jaume Martinez, Unitat Terapéutica de Justica Juvenil Els Til lers. Barcelona, España. SPECIFICS OF THE MANAGEMENT AND TREATMENT OF DUAL PATHOLOGY IN TEENAGERS WITH MANY PROBLEMATIC QUESTIONS Jaume Claramunt, Parc Sanitari Sant Joan de Deu. Barcelona, España. Workshop - WS05 ADDICTION TO INFORMATION TECHNOLOGY AND COMMUNICATION AND BORDERLINE PERSONALITY DISORDER Maite Utges, Hospital Santa Maria. Lleida, España. THE ADDICTION TO INFORMATION TECHNOLOGY AND COMMUNICATION AND BORDERLINE PERSONALITY DISORDER, A DANGEROUS COMBINATION Maite Utges, Hospital Santa Maria. Lleida, España. APPROPRIATE USE OF INFORMATION AND COMMUNICATION TECHNOLOGIES (ICTS) IN THE TREATMENT OF BORDERLINE PERSONALITY DISORDER (BPD) Enrique Díaz, Hospital de Santa María, Lleida, España. 4:00 5:30 Oral Communications - OC03 Pág. 6

17 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Room Chairs: José M. Goikolea, Hospital Clinic, Barcelona, España. Pier P. Pani, Social-Health Services, Health District 8, Cagliari, Italy. FORENSIC PSYCHIATRIC SERVICES IN THE ARAB WORLD, THE PAST AND THE FUTURE Hasanen Al-Taiar, Saif Al-Hashimi, Moustafa Hussien Soltan 3 Oxford Health NHS Foundation Trust, United Kingdom. Armed Forces Hospital. Muscat, Oman. 3 Egypt. ABUSE OF VIDEO GAMES AND THE INTERNET IN A CASE OF AUTISM R. Cappai, S. Marras, I. Obbili Studio di Psicologia, Costruttivamente. Cagliari, Italy. AN EXPLORATORY ONLINE SURVEY ON THE PREVALENCE OF HYPERSEXUAL BEHAVIOUR R. Gupta, D. Deka, YPS. Balhara All India Institute of Medical Sciences, New Delhi, India. LIMES, LIMEN. BORDERLINE PERSONALITY DISORDER AND SUBSTANCES ABUSE: TWO LINKED PATHOLOGIES ON THE BORDER BETWEEN NEUROLOGY AND PSYCHIATRY, LAW AND CLINIC Marco Mollica, Veronica Aiello DINOGMI, Section of Psychiatry, University of Genoa, San Martino Hospital, Largo Rosanna Benzi, Genoa, Liguria, Italy. FEATURES AND PERMANENCE IN TREATMENT OF A SAMPLE OF DRUG USERS LEGALLY CONDITIONED TO TAKE TREATMENT IN CENTERS OF YOUTH INTEGRATION TLALPAN C. Tejeda Romero, DB Díaz Negrete Centros de Integración, Tlalpan, DF, México. Centros de Integración Juvenil, DF, México. BUILDING AN INDIVIDUALIZED PROFILE FOR TREATMENT ACROSS BEHAVIORAL ADDICTIONS N. el-guebaly. University of Calgary, Alberta, Canada. Alberta Gambling Research Institute, Alberta, Canada. NURSING INTERVENTION IN DRUG ADDICTION CENTERS (CAD) PROTOCOL S. Gutiérrez Cáceres, J. Chicharro Romero, M. Sáez García 3, D. Coca Pérez 4, J. Martín Herrero 5, N. García Hidalgo 6, N. Salgado Marcos 6, C. López Jiménez 5, A. Vicente Partido 7, C. Culebras García 5 DUE CAD Latina, Madrid, España. DUE CAD San Blas, Madrid, España. 3 DUE CAD Hortaleza, Madrid, España. 4 DUE CAD Tetuan, Madrid, España. Pág. 7

18 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 5 DUE CAD Arganzuela, Madrid, España. 6 DUE CAD Vallecas, Madrid, España. 7 DUE CAD Villaverde, Madrid, España. 5:30 7:00 h. 5:30 7:00 Room Track: Psychosis 5:30 7:00 Room -3 Track: Cannabis and Dual 5:30 7:00 Room 4 Track: Training Dual Diagnosis Symposium SY9 ARE THERE CLINICAL-NEUROBIOLOGICAL DIFFERENCES BETWEEN CANNABIS USERS WITH PSYCHOSIS AND NON-USERS WITH PSYCHOSIS? Francisco Arias, Hospital Doce de Octubre. Madrid, España. GENETIC VULNERABILITY TO PSYCHOSIS IN CANNABIS USERS AND NON-USERS Francisco Arias, Hospital Doce de Octubre. Madrid, España. CLINICAL AND PREPULSE INHIBITION DEFICIT DIFFERENCES BETWEEN CANNABIS-INDUCED PSYCHOTIC DISORDER AND SCHIZOPHRENIA Gabriel Rubio, Universidad Complutense de Madrid. Madrid, España. DIFFERENCES IN TREATMENT AND EVOLUTION BETWEEN CANNABIS USERS AND NON- USERS AFTER STARTING THE FIRST PSYCHOTIC EPISODE PROGRAMME CARRIED OUT AT THE TH OCTOBER HOSPITAL, MADRID. Isabel Martínez, Hospital Doce de Octubre. Madrid, España. Debate Forum - DF07 CANNABIS: NEW INTERNATIONAL REGULATION. WHAT IS THE RISK IN DUAL DISORDERS? Manuel Mas-Bagá, CAT Barcelona, España. NEW POLITICS ABOUT CANNABIS: AN OPORTUNITY IN PUBLIC HEALTH? Joan Colom, Agència de Salut Pública de Catalunya, BarcOC0elona, España. CANNABIS USE IN THE USA Ruben Baler, National Institute on Drug Abuse. MD, USA. LEGALIZATION OF THE USE OF CANNABIS Cecilia Idiarte, Sociedad de Psiquiatría del Uruguay, Uruguay. Invited Symposium IS06 WHERE ARE DUAL DISORDERS IN DSM5? Marta Torrens, Institut de Neuropsiquiatria I Addiccions-Parc de Salut Mar, Universitat Autònom, Barcelona, España. SUBSTANCE-RELATED AND ADDICTIVE DISORDERS IN DSM-5: WHAT'S NEW? Marc Auriacombe, Faculté de Médecine, Université de Bordeaux, France. DUAL DISORDERS IN DSM-5: AN OVERVIEW Deborah Hasin, New York State Psychiatric Institute, Columbia University. NY, USA. SOME EXAMPLES OF COMORBIDITY WITH SUD IN DSM-5 Pág. 8

19 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Frances Levin, New York Presbiterian Hospital, NYS Psychiatric Institute. NY, USA. 5:30 7:00 Room 5 Track: Penitentiary (Prisons) & Dual Pathology 5:30 7:00 Room 6 Track: Evaluation processes in Dual 5:30 7:00 Room 7 Track: Alcohol 5:30 7:00 Room 8 Symposium - SY0 REHAB PROJECT AND OTHER DUAL DISORDERS APPROACHES IN EUROPEAN PRISONS Fabio Sternberg, Federación Europea de Sanidad Penitenciaria. Barcelona, España. DUAL DISORDERS APPROACH IN SPANISH PRISONS José M. Antolín, Sociedad Española de Sanidad Penitenciaria (SESP). Barcelona, España. DUAL DISORDERS APPROACH IN FRENCH PRISONS Fadi Meroueh, Asociación de Profesionales Sanitarios en Prisión (APSEP), Francia. Cyril Manzanares, Servicios Médicos de la Prisión Villeneuve Les Maguelone - CHU Montpellier, France. REHAB PROJECT AS AN APPROACH IN DUAL DISORDERS IN PRISON. THE VITERBO-ITALY EXPERIENCE Roberto Monarca, Sociedad Italiana de Medicina y Sanidad Penitenciaria (SIMSPe), Italy. Symposium - SY OUTCOME MEASURES IN HEROIN ADDICTED PATIENTS WITH DUAL DISORDERS TREATED WITH OPIOID AGONIST MEDICATIONS Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital, Pisa, Italy. INCREASING IMPORTANCE OF MEASURING OUTCOMES IN OPIOID DEPENDENCE CARE Icro Maremmani, University of Pisa, University of Siena, Santa Chiara University Hospital, Pisa, Italy. STUDYING PSYCHOPATHOLOGY OF HEROIN ADDICTS AS OUTCOME MEASURES Pier P. Pani, Social-Health Services, Health District 8 (ASL 8) Cagliari, Italy. QUALITY OF LIFE AND CRAVING BEHAVIOUR AS OUTCOME MEASURES IN HEROIN ADDICTS Angelo G.I. Maremmani, University of Pisa. Pisa, Italy. Symposium - SY ALCOHOL CONSUMPTION DURING ADOLESCENCE AS A VULNERABILITY FACTOR IN DUAL DISORDERS Olga Valverde, Universitat Pompeu Fabra. Barcelona, España. DELETERIOUS EFFECTS OF ALCOHOL CONSUMPTION DURING CRITICAL PERIODS OF LIFE Olga Valverde, Universitat Pompeu Fabra. Barcelona, España. ETHANOL, STRESS AND ADOLESCENCE Marta Rodríguez-Árias, Universidad de Valencia. Comunidad Valenciana, España. NEUROCHEMICAL AND BEHAVIORAL CHANGES INDUCED BY MATERNAL SEPARATION AND VULNERABILITY TO ALCOHOL CONSUMPTION IN MICE Jorge Manzanares, Universidad Miguel Hernández. Alicante, España. ADDICTION RESEARCH AND HUMAN PHARMACOLOGY GROUPS, NEUROSCIENCES RESEARCH PROGRAM, IMIM Francina Fonseca, Hospital del Mar. Barcelona, España. Debate Forum - DF08 MULTIDISCIPLINARITY IN DUAL PATHOLOGY AND ITS KEYS: PSYCHOLOGICAL Pág. 9

20 Saturday April 8 th PRELIMINARY PROGRAM - UPDATED: 9/04/05 Track: Psychotherapeutic Treatment in Dual 5:30 7:00 Room 9 5:30 7:00 Room 0 Track: Attention Deficit 5:30 6:5 Room Track: Transcultural Psychiatry INTERVENTION José A. Carrobles, Universidad Autónoma de Madrid, España. TRANSDIAGNOSIS AND DUAL PATHOLOGY José A. Carrobles, Universidad Autónoma de Madrid, España. ROLE OF THE PSYCHOLOGIST: THE NEED TO INTEGRATE THE DISCIPLINE IN DUAL PATHOLOGY Mª Nieves Gómez, Ayuntamiento San Sebastian de Los Reyes, Madrid, España. THE ROLE OF THE PSYCHOLOGIST IN DUAL PATHOLOGY IN AN INTERDISCIPLINARY ADDICTIONS CARE TEAM Marcela Coromina, Centre d'atenció i Seguiment Sarrià, Centre d'atenció i Seguiment Baluard. Barcelona, España. Medical Educational Room Sponsored by the Foundation on Dual Symposium SY3 ADDICTIVE DISORDERS IN ADHD PATIENTS: A SELF-MEDICATION PROBLEM? Jorge Jaber, Clínica Jorge Jaber. Rio de Janeiro, Brasil. ADDICTIVE DISORDERS IN ADHA PATIENTS José Temótio, Unidade Patologia Dual. C.H.U. Coimbra, Portugal. NEUROBIOLOGY OF ADHA AND ADDICTIVE DISORDERS Eugenio H. Grevet, Federal University of Rio Grande do Sul (UFRGS). Porto Alegre Clinical Hospital. Porto Alegre, Brasil. SELF-MEDICATION HYPOTHESIS IN ADDICTIVE DISORDERS IN ADHA PATIENTS Célia Franco, Unidade Patologia Dual. C.H.U. Coimbra, Portugal. Workshop - WS06 BETWEEN EAST AND WEST: CHALLENGES IN TREATMENT OF PATIENTS WITH DUAL DISORDERS Andrej Kastelic, Center for Treatment of Drug Addiction, University Psychiatric Hospital Ljubljana, Slovenia. ARE THEY (WE) DIFFERENT? Nusa Segrec, Center for Treatment of Drug Addiction, University Psychiatric Clinic Ljubljana, Slovenia. BREAKING BARRIERS FOR TREATMENT OF DRUG USERS WITH DUAL DIAGNOSES WITH AIM TO IMPROVE THE ACCESS AND QUALITY OF TREATMENT Ljiljana Ignjatova, Psychiatric Hospital Skopje. Skopje, Macedonia. HOW STIGMA WILL DELAY A TREATMENT Luis Patricio, Casa de Saude De Carnaxide. Carnaixade, Portugal. Pág. 0